Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial. - Finkel RS; Crawford TO; Mercuri E; Sumner CJ; Garcia Romero MDM; Day JW; Montes J; Sun P; Tichler B; Paradis AD; Boesch E; Inra J; et al. (Nature medicine, 2026)